Antibody testing

Davio et al. (43) report efforts to obtain monoclonal antibodies (mAbs) to STX. Because STX is a small molecule of approximately 300 daltons, well below the size necessary for immunogenicity, a carrier molecule must be conjugated to the hapten (STX). This technique must minimize alterations of the antigenic form. For the anti-STX antibodies tested to date, the ratios of immunoassay response factor to pharmacological potency for various STX derivatives differ substantially, the immunoassay being virtually unresponsive to some of the common natural derivatives (44). 

Sensitive techniques are available to detect E. histolytica in stool antigen detection, antibody test (ELISA) and PCR. 

I direct fluorescent monoclonal antibody test. Given the fact that most women are asymptomatic, an annual screening or physical is necessary, as early detection may reduce rates of transmission. 

Diagnostic procedures include dark-field microscopy12, non-treponemal exams10 (i.e., the Venereal Disease Laboratory and the rapid plasma reagin test), and treponemal exams (i.e., enzyme immunoassay, the T. pallidum hemagglutination test, the fluorescent treponemal antibody test, and the enzyme-linked immunosorbent assay). 

Acute HIV Infection Diagnosis of acute HIV infection is difficult, since many patients are asymptomatic, or have nonspecific clinical symptoms similar to other common respiratory infections. If acute HIV infection is suspected, HIV antibody tests and a plasma HIV RNA concentration should be obtained. A clear diagnosis is made when an HIV antibody test is negative and the plasma HIV RNA concentration is high. There are limited outcomes data for treating acutely infected patients. Treatment of acute infection can decrease the severity of acute disease and decrease the viral set point this may decrease progression rates and reduce the rate of viral transmission.18-22 Limitations include an increased risk of chronic drug-induced toxicides and the development of viral resistance. 

Although the novel AR protocol using citraconic anhydride improved the intensity of IHC on FFPE tissue sections for more than half of the antibodies tested, compared to that achieved by other conventional AR protocols, not all antibodies benefitted, which would argue that the citraconic anhydride method does not serve as a truly universal AR protocol. Indeed, many investigators (Table 1.2) have concluded that different antigens may require different specific AR protocols. In this respect, the test battery is a convenient and cost-effective method for assessing the appropriate AR protocol.2,8 Nevertheless, the present data certainly support inclusion of the citraconic anhydride AR method in such a test battery. With respect to the two heating temperatures for citraconic anhydride, the ultimate choice of method for any laboratory may depend on the equipment available. 

Battifora H. The multitumor (sausage) tissue block novel method for immuno-histochemical antibody testing. Lab. Invest. 1986 55 244-248. 

CDC Case Definition Laboratory criteria for diagnosis is (1) a positive direct fluorescent antibody test (preferably performed on central nervous system tissue) or (2) isolation of rabies virus (in cell culture or in a laboratory animal). 

Testing for HP is only recommended if eradication therapy is considered. If endoscopy is not planned, serologic antibody testing is reasonable to determine HP status. The UBT is the preferred nonendoscopic method to verify HP eradication after treatment. 

In most patients, serologic evidence remains the primary method in the diagnosis of histoplasmosis. Results obtained from complement fixation, immunodiffusion, and latex antigen agglutination antibody tests are used... 

Rapid antigen and point-of-care tests, direct fluorescence antibody test, and the reverse-transcription polymerase chain reaction assay may be used for rapid detection of virus. 

Laboratory findings include leukocytosis with predominance of mature and immature granulocytes in 50% to 75% of patients. Because L. pneumophila stains poorly with commonly used stains, routine microscopic examination of sputum is of little diagnostic value. Fluorescent antibody testing can be performed to diagnose Legionnaires disease. 

Tests that allow rapid identification of chlamydial antigens in genital secretions are the direct fluorescent antibody test, the enzyme immunoassay (requires just 30 minutes for results), the DNA hybridization probe and nucleic acid amplification tests. 

In 1982 (M2), the Centers for Disease Control (CDC) in Atlanta defined a patient with AIDS as a person with a reliably diagnosed disease indicative of an underlying cellular immune deficiency, for example, Kaposi s sarcoma in patients less than 60 years old, provided they have no other cause of cellular immune deficiency. The definition was revised in 1985 and 1987 to include the advent of HIV antibody testing. 

It is important to note that these figures represent HIV-infected individuals detected by antibody test, and not AIDS cases. Since most of these individuals acquired the virus relatively recently, most have not yet begun to show signs of illness. However, we can predict that within a few years the number of AIDS cases in these countries will soar. 

Receiving a transfusion of HIV-infected blood. Since transfusion involves placing foreign blood or blood products directly into the recipient s bloodstream, the necessary conditions for HIV transmission are present. After screening of the blood supply by antibody tests began in 1985, the risk was low that the blood or blood product involved in transfusion was infected, except for hemophiliacs, who require a clotting factor extracted from the blood of many different donors. 

Within a year of the isolation of HIV as the causative agent of AIDS, a test was developed that determines if an individual has been exposed to HIV. The procedure is to test whether an individual has antibodies to HIV virus proteins. The most common HIV antibody test is an ELISA test. 

False Negatives. A more important problem is individuals who are infected with HIV but who do not score positive in the HIV antibody test. Such individuals fall into two categories ... 

Recently infected individuals. The immune system has a lag period between initial exposure to an antigen and the production of antibodies. In the case of HIV infection, this lag can range up to six months or longer. Thus, individuals who have been recently infected with HIV will not score positive in the antibody test. 

The HIV antibody test measures whether an individual has circulating antibodies to HIV. However, strictly speaking, the test does not indicate if an antibody positive individual still harbors infectious virus. Some individuals who are exposed to HIV might have raised a successful immune response and completely eliminated the infection. However, by and large, most HIV-antibody positive individuals turn out to be still infected. 

Antibody test Blood tests that detect A positive test... 

Antibodies Formation of antihirudin antibodies was observed in approximately 40% of HIT patients treated with lepirudin. This may increase the anticoagulant effect of lepirudin possibly because of delayed renal elimination of active lepirudin-antihirudin complexes. Therefore, strict monitoring of aPTT is necessary also during prolonged therapy. No evidence of neutralization of lepirudin or of allergic reactions associated with positive antibody test results was found. 

HiV resistance Prior to initiating adefovir therapy, offer HIV antibody testing to all patients. Treatment with antihepatitis B therapies, such as adefovir, that have activity against HIV in a chronic hepatitis B patient with unrecognized or untreated HIV infection may result in emergence of HIV resistance. 

Hospital and commercial diagnostic testing laboratories rely on monoclonal antibody tests to measure the amounts of specific proteins, hormones, or drugs in blood. Monoclonal antibodies tagged to fluorescent dyes are also used with lasers to determine the kind of tumor a patient has, to track the number of tumor cells, and to monitor the level of immune system cells. The CD4 count test, important to patients with HIV infection, uses monoclonal antibodies and a laser-driven device that checks cell by cell for the CD4 protein, the marker for the critical immune system cell. The same technology and a set of antibodies to immune system cell proteins are used to diagnose children suspected of having inherited an immune system deficiency. 

---